AI uncovers significant misdiagnoses in carcinoma type, study shows
Caris Life Sciences, an AI-powered biotech and precision medicine company, has published a new study in JAMA Network Open titled, "An AI Approach to Differentiating Lung Squamous Cell Carcinoma From Metastases of Other Origins." The company says the report builds on the body of evidence showing the effectiveness of its proprietary GPSai algorithm over traditional diagnostic procedures in correctly diagnosing cancer types.
Original Source
Read the full article at Healthcareitnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.